A Phase-1 vaccine study result should not be used to extrapolate efficacy. It is designed to determine the vaccine’s safety profile. Patience required for the results of the next two trial phases to truly answer the efficacy question.

Medical Mythbusting Commentary for July 15, 2020


Covid-19 vaccine hopes raised as trial of Moderna’s experimental jab shows ALL 45 injected volunteers developed antibodies